ClinicalTrials.gg
Drug

Delgocitinib clinical trials

Also written LEO 124249.

studies test it
26
open now
6
in phase 3
7
first study started
2016

How each study uses delgocitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the delgocitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Jul 2025 · ANZUPGO · NDA 219155 (FDA, Drugs@FDA)
European Union
19 Sept 2024 · Anzupgo · EMEA/H/C/006109 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Delgocitinib cream
11
Delgocitinib
10
LEO 124249 cream
8
LEO 124249 ointment
2

Brand

Anzupgo
1

Development codes

LEO 124249
3

Studies by the year they started

26 studies that test it; most in 2026 (6)

Studies that test delgocitinib, by start year
YearStudies
20163
20171
20182
20192
20201
20215
20224
20231
20251
20266

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
4
Phase 2
13
Phase 3
7
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 5

LEO Pharma (21) · Lone Skov (1) · Maryanne Makredes Senna (1) · Aarhus University Hospital (1) · Aalborg University (1) · Icahn School of Medicine at Mount Sinai (1)

Often tested with

Tested in the same studies.

Lidocaine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test delgocitinib.

Studies

Open first, then newest update. How each study uses delgocitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test delgocitinib →

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call delgocitinib · ClinicalTrials.gg INT000743

  • MeSH (NLM) C000621572delgocitinibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 9L0Q8KK220DELGOCITINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q76620858delgocitinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171928DelgocitinibOne source FDA
  • DrugBank DB16133One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.